Mohiuddin Shamsi
Foot & Ankle Surgery · Lake Jackson, TXNPI 1588922686
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,272 of the $8,428 with a category attached, or 74.4%. Stryker accounts for 72.1% of it on its own, with 20 other manufacturers making up the rest.
Across 126 payments — averaging $66.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$6K
- Paragon 28, Inc.$697
- Amgen$359
- Johnson & Johnson$261
- Smith+Nephew$154
- Aroa Biosurgery Incorporated$144
- plus $735 from 15 others
Across 5 payments — averaging $2561.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$13K
What the payments were for
- Travel & lodging$2,15526%
- Food & beverage$6,27274%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 74 | $6,078 |
| Paragon 28, Inc. | 5 | $697 |
| Amgen | 6 | $359 |
| Johnson & Johnson | 6 | $261 |
| Smith+Nephew | 4 | $154 |
| Aroa Biosurgery Incorporated | 2 | $144 |
| Organogenesis Inc. | 1 | $133 |
| Melinta Therapeutics, LLC | 4 | $121 |
| Osiris Therapeutics Inc. | 1 | $96 |
| Zimmer Biomet | 4 | $82 |
| Zyla Life Sciences, Inc. | 5 | $68 |
| Medtronic | 2 | $65 |
| Paratek Pharmaceuticals, Inc. | 2 | $30 |
| Merck | 2 | $28 |
| Assertio Therapeutics, Inc. | 2 | $26 |
| Arthrosurface Incorporated | 1 | $17 |
| Cardiovascular Systems Inc. | 1 | $17 |
| Treace Medical Concepts, Inc. | 1 | $15 |
| AbbVie | 1 | $14 |
| Misonix Inc | 1 | $12 |
| Acell, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRIME SERIES$1,097
- VARIAX$829
- Portfolio$634
- PROPHECY$437
- RAYOS$350
- ANCHORAGE$308
- SONICANCHOR$308
- SMARTTOE$308
- ASNIS$304
- AUGMENT INJECTABLE$173
- ALLOWRAP$173
- ALLOGRAFT$173
- ORTHOLOC 2 LAPIFUSE$170
- FIXOS$155
- REELX STT$149
- NuCel$133
- CANNULATE SCREW SYSTEM$130
- KRYSTEXXA$100
How this compares
$8,428 in reported general payments places this provider in the 70th percentile of 684 foot & ankle surgery providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 100 | $554 |
| Terbinafine Hcl | 25 | $452 |
| Diclofenac Sodium | 41 | $393 |
| Ciclopirox | 15 | $365 |
| Gabapentin | 43 | $296 |
| Meloxicam | 51 | $217 |
| Ketoconazole | 19 | $148 |
| Nystatin | 14 | $102 |
| Cephalexin | 14 | $69 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Lake Jackson
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.